Therefore, many studies have been focused on the roles of Irisin in the treatment of metabolic disorders such as obesity and type 2 diabetes, and less is known of Irisin’s roles during pregnancy. Here, FNDC5 is linked to obesity due to melanocortin 4 receptor deficiency.